Salt Lake City, UT, United States of America

Sean V Tavtigian

USPTO Granted Patents = 26 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.3

ph-index = 13

Forward Citations = 370(Granted Patents)

Location History:

Lyons, FR (2010)
Salt Lake City, UT (US) (1998 - 2014)

Company Filing History:

16 out of 116

Myriad Genetics, Inc.

patents

5 out of 1,650

University of Utah Research Foundation

patents

3 out of 5,463

The University of Texas System

University of Pennsylvania

patents

6. 2 out of 2

Myraid Genetics, Inc.

patents

7. 2 out of 28

The United States of America as Represented by the Secretary of Health

patents

8. 2 out of 1,217

The United States of America as Represented by the Department of Health

patents

9. 1 out of 36

Hsc Research and Development Limited Partnership

patents

10. 1 out of 1

Hsc Research & Development Limited Parntership

patent

11. 1 out of 1

Myriad Genectics, Inc.

patent

12. 1 out of 1

Hsc Reseach & Development Limited Partnership

patent

13. 1 out of 165

The Hospital for Sick Children

patents

14. 5 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2014

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8735066 - Tumor suppressor designated TS10Q23.3 (2014-05-27),

2. 7732576 - Tumor suppressor designated TS10Q23.3 (2010-06-08),

3. 7217795 - Tumor suppressor designated TS10q23.3 (2007-05-15),

4. 7129040 - Tumor suppressor designated TS10q23.3 (2006-10-31),

5. 6844189 - Chromosome 17P-linked prostate cancer susceptibility gene (2005-01-18),

6. 6482795 - Tumor suppressor designated TS10q23.3 (2002-11-19),

7. 6465629 - BRG1 is a tumor suppressor that is mutated in prostate and other cancer types (2002-10-15),

8. 6444419 - TMPRSS2 is a tumor suppressor (2002-09-03),

9. 6440699 - Prostate cancer susceptible CA7 CG04 gene (2002-08-27),

10. 6337192 - MMSC1-an MMAC1 interacting protein (2002-01-08),

11. 6333403 - Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes (2001-12-25),

12. 6331614 - Human CDC14A gene (2001-12-18),

13. 6291173 - MMSC2—an MMAC1 interacting protein (2001-09-18),

14. 6262242 - Tumor suppressor designated TS10Q23.3 (2001-07-17),

15. 6235263 - Carboxy-terminal BRCA1 interacting protein (2001-05-22),

Title: The Innovative Journey of Sean V Tavtigian

Introduction:

Sean V Tavtigian is a renowned inventor based in Salt Lake City, UT (US) known for his groundbreaking contributions to the field of technology and science.

Latest Patents:

Sean V Tavtigian holds several patents in the areas of biotechnology, genetics, and medical devices, showcasing his commitment to pushing the boundaries of innovation.

Career Highlights:

With a career spanning over two decades, Sean V Tavtigian has worked tirelessly to develop cutting-edge solutions that have revolutionized the industry. His keen eye for detail and passion for discovery have led to numerous breakthroughs.

Collaborations:

Throughout his career, Sean V Tavtigian has collaborated with leading researchers, scientists, and institutions to further his research and bring his inventions to life. His collaborative spirit has been instrumental in his success.

Conclusion:

In conclusion, Sean V Tavtigian's dedication to innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire and shape the future of technology and science.

This text is generated by artificial intelligence and may not be accurate.